Corus report incorrect

Dear Sir,
Our attention has been drawn to an article printed in your January 2004 issue entitled  ‘Corus wins back rights to market Versacor’.
Corus have been warned that their making public statements which misinterpret the results of last year's London High Court case and which consequently undermine Centria’s lawful rights to sell Versacor materials would expose them to a claim for unlawful interference with our business.
For the record, a summary of the UK High Court ruling is that Corus are a non-exclusive licensee in Versacor. Centria are an exclusive licensee in Versacor in the territories of the Americas and a non-exclusive licensee outside of that territory. This ruling therefore does not prevent Centria from the marketing and sale of Versacor product in the Middle East, nor does it expose us to any threat of action by Corus.
Versacor is a trademark registered to Centria in the territories of the UAE, Kuwait, Bahrain and Saudi Arabia, with pending registrations throughout most of the rest of the Middle East. This fact prevents Corus from legally using the trademark Versacor on any product they may offer in these markets and in using this mark they would be in breach of the respective laws on intellectual property rights.
Adrian Jones
Regional Manager
Centria International